Do analysts recommend SNYR or ATPC?

Synergy CHC presently has a consensus target price of $6.25, suggesting a potential upside of 5,581.82%. Given Synergy CHC's stronger consensus rating and higher possible upside, equities analysts plainly believe Synergy CHC is more favorable than Agape ATP. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is SNYR or ATPC more profitable?

Synergy CHC has a net margin of -60.02% compared to Agape ATP's net margin of -85.94%. Synergy CHC's return on equity of 0.00% beat Agape ATP's return on equity. Company Net Margins Return on Equity Return on Assets Synergy CHC -60.02% N/A -30.30% Agape ATP -85.94% -5.47% -4.94%

Do analysts recommend SNYR or DSYWW?

Synergy CHC currently has a consensus target price of $6.25, suggesting a potential upside of 5,581.82%. Given Synergy CHC's stronger consensus rating and higher possible upside, equities research analysts clearly believe Synergy CHC is more favorable than Big Tree Cloud. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Big Tree Cloud 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher earnings & valuation, SNYR or DSYWW?

Big Tree Cloud has lower revenue, but higher earnings than Synergy CHC. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synergy CHC $30.38M 0.05 -$12.34M -$1.40 N/A Big Tree Cloud $2.02M N/A N/A N/A N/A

Is SNYR or DSYWW more profitable?

Big Tree Cloud has a net margin of 0.00% compared to Synergy CHC's net margin of -60.02%. Company Net Margins Return on Equity Return on Assets Synergy CHC -60.02% N/A -30.30% Big Tree Cloud N/A N/A N/A

Do analysts prefer SNYR or DRMAW?

Synergy CHC presently has a consensus target price of $6.25, indicating a potential upside of 5,581.82%. Given Synergy CHC's stronger consensus rating and higher possible upside, equities analysts plainly believe Synergy CHC is more favorable than Dermata Therapeutics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Dermata Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher earnings & valuation, SNYR or DRMAW?

Dermata Therapeutics has lower revenue, but higher earnings than Synergy CHC. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synergy CHC $30.38M 0.05 -$12.34M -$1.40 N/A Dermata Therapeutics N/A N/A N/A N/A N/A

Is SNYR or DRMAW more profitable?

Dermata Therapeutics has a net margin of 0.00% compared to Synergy CHC's net margin of -60.02%. Company Net Margins Return on Equity Return on Assets Synergy CHC -60.02% N/A -30.30% Dermata Therapeutics N/A N/A N/A

Do analysts rate PRENW or SNYR?

Synergy CHC has a consensus target price of $6.25, suggesting a potential upside of 5,581.82%. Given Synergy CHC's stronger consensus rating and higher possible upside, analysts clearly believe Synergy CHC is more favorable than Prenetics Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prenetics Global 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Which has better valuation & earnings, PRENW or SNYR?

Prenetics Global has higher revenue and earnings than Synergy CHC. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Prenetics Global $154.59M N/A N/A N/A N/A Synergy CHC $30.38M 0.05 -$12.34M -$1.40 N/A

Is PRENW or SNYR more profitable?

Prenetics Global has a net margin of 0.00% compared to Synergy CHC's net margin of -60.02%. Company Net Margins Return on Equity Return on Assets Prenetics Global N/A N/A N/A Synergy CHC -60.02% N/A -30.30%

Do analysts rate SNYR or WALDW?

Synergy CHC currently has a consensus target price of $6.25, indicating a potential upside of 5,581.82%. Given Synergy CHC's stronger consensus rating and higher probable upside, research analysts clearly believe Synergy CHC is more favorable than Waldencast. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Waldencast 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation and earnings, SNYR or WALDW?

Waldencast has higher revenue and earnings than Synergy CHC. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synergy CHC $30.38M 0.05 -$12.34M -$1.40 N/A Waldencast $272.07M N/A N/A N/A N/A

Is SNYR or WALDW more profitable?

Waldencast has a net margin of 0.00% compared to Synergy CHC's net margin of -60.02%. Company Net Margins Return on Equity Return on Assets Synergy CHC -60.02% N/A -30.30% Waldencast N/A N/A N/A

Synergy CHC (SNYR) Competitors

$0.11 0.00 (-1.79%)

As of 09/3/2026 04:00 PM Eastern

Compare

SNYR vs. ATPC, DSYWW, DRMAW, PRENW, and WALDW

Should you buy Synergy CHC stock or one of its competitors? Synergy CHC's main competitors and comparable companies include Agape ATP (ATPC), Big Tree Cloud (DSYWW), Dermata Therapeutics (DRMAW), Prenetics Global (PRENW), and Waldencast (WALDW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does Synergy CHC compare to Agape ATP?

Synergy CHC (NASDAQ:SNYR) and Agape ATP (NASDAQ:ATPC) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

Synergy CHC has a beta of -0.25, indicating that its share price is 125% less volatile than the broader market. Comparatively, Agape ATP has a beta of 0.4, indicating that its share price is 60% less volatile than the broader market.

Synergy CHC has a net margin of -60.02% compared to Agape ATP's net margin of -85.94%. Synergy CHC's return on equity of 0.00% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synergy CHC	-60.02%	N/A	-30.30%
Agape ATP	-85.94%	-5.47%	-4.94%

In the previous week, Synergy CHC's average media sentiment score of 0.00 equaled Agape ATP'saverage media sentiment score.

Company	Overall Sentiment
Synergy CHC	Neutral
Agape ATP	Neutral

0.0% of Agape ATP shares are owned by institutional investors. 32.9% of Synergy CHC shares are owned by company insiders. Comparatively, 2.0% of Agape ATP shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Agape ATP has lower revenue, but higher earnings than Synergy CHC. Agape ATP is trading at a lower price-to-earnings ratio than Synergy CHC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synergy CHC	$30.38M	0.05	-$12.34M	-$1.40	N/A
Agape ATP	$1.52M	1.57	-$2.28M	-$0.74	N/A

Synergy CHC presently has a consensus target price of $6.25, suggesting a potential upside of 5,581.82%. Given Synergy CHC's stronger consensus rating and higher possible upside, equities analysts plainly believe Synergy CHC is more favorable than Agape ATP.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Synergy CHC beats Agape ATP on 8 of the 14 factors compared between the two stocks.

How does Synergy CHC compare to Big Tree Cloud?

Synergy CHC (NASDAQ:SNYR) and Big Tree Cloud (NASDAQ:DSYWW) are both consumer staples companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation.

Synergy CHC currently has a consensus target price of $6.25, suggesting a potential upside of 5,581.82%. Given Synergy CHC's stronger consensus rating and higher possible upside, equities research analysts clearly believe Synergy CHC is more favorable than Big Tree Cloud.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Big Tree Cloud	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Big Tree Cloud has a net margin of 0.00% compared to Synergy CHC's net margin of -60.02%.

Company	Net Margins	Return on Equity	Return on Assets
Synergy CHC	-60.02%	N/A	-30.30%
Big Tree Cloud	N/A	N/A	N/A

In the previous week, Synergy CHC's average media sentiment score of 0.00 equaled Big Tree Cloud'saverage media sentiment score.

Company	Overall Sentiment
Synergy CHC	Neutral
Big Tree Cloud	Neutral

Big Tree Cloud has lower revenue, but higher earnings than Synergy CHC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synergy CHC	$30.38M	0.05	-$12.34M	-$1.40	N/A
Big Tree Cloud	$2.02M	N/A	N/A	N/A	N/A

Summary

Synergy CHC beats Big Tree Cloud on 4 of the 6 factors compared between the two stocks.

How does Synergy CHC compare to Dermata Therapeutics?

Synergy CHC (NASDAQ:SNYR) and Dermata Therapeutics (NASDAQ:DRMAW) are both consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

Dermata Therapeutics has a net margin of 0.00% compared to Synergy CHC's net margin of -60.02%.

Company	Net Margins	Return on Equity	Return on Assets
Synergy CHC	-60.02%	N/A	-30.30%
Dermata Therapeutics	N/A	N/A	N/A

In the previous week, Synergy CHC's average media sentiment score of 0.00 equaled Dermata Therapeutics'average media sentiment score.

Company	Overall Sentiment
Synergy CHC	Neutral
Dermata Therapeutics	Neutral

Synergy CHC presently has a consensus target price of $6.25, indicating a potential upside of 5,581.82%. Given Synergy CHC's stronger consensus rating and higher possible upside, equities analysts plainly believe Synergy CHC is more favorable than Dermata Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Dermata Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Dermata Therapeutics has lower revenue, but higher earnings than Synergy CHC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synergy CHC	$30.38M	0.05	-$12.34M	-$1.40	N/A
Dermata Therapeutics	N/A	N/A	N/A	N/A	N/A

Summary

Synergy CHC beats Dermata Therapeutics on 4 of the 6 factors compared between the two stocks.

How does Synergy CHC compare to Prenetics Global?

Prenetics Global (NASDAQ:PRENW) and Synergy CHC (NASDAQ:SNYR) are both consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

Prenetics Global has higher revenue and earnings than Synergy CHC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$154.59M	N/A	N/A	N/A	N/A
Synergy CHC	$30.38M	0.05	-$12.34M	-$1.40	N/A

In the previous week, Prenetics Global's average media sentiment score of 0.00 equaled Synergy CHC'saverage media sentiment score.

Company	Overall Sentiment
Prenetics Global	Neutral
Synergy CHC	Neutral

Prenetics Global has a net margin of 0.00% compared to Synergy CHC's net margin of -60.02%.

Company	Net Margins	Return on Equity	Return on Assets
Prenetics Global	N/A	N/A	N/A
Synergy CHC	-60.02%	N/A	-30.30%

Synergy CHC has a consensus target price of $6.25, suggesting a potential upside of 5,581.82%. Given Synergy CHC's stronger consensus rating and higher possible upside, analysts clearly believe Synergy CHC is more favorable than Prenetics Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

Prenetics Global and Synergy CHC tied by winning 3 of the 6 factors compared between the two stocks.

How does Synergy CHC compare to Waldencast?

Synergy CHC (NASDAQ:SNYR) and Waldencast (NASDAQ:WALDW) are both consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, media sentiment, risk and analyst recommendations.

Synergy CHC currently has a consensus target price of $6.25, indicating a potential upside of 5,581.82%. Given Synergy CHC's stronger consensus rating and higher probable upside, research analysts clearly believe Synergy CHC is more favorable than Waldencast.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Waldencast	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Waldencast has higher revenue and earnings than Synergy CHC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synergy CHC	$30.38M	0.05	-$12.34M	-$1.40	N/A
Waldencast	$272.07M	N/A	N/A	N/A	N/A

In the previous week, Synergy CHC's average media sentiment score of 0.00 equaled Waldencast'saverage media sentiment score.

Company	Overall Sentiment
Synergy CHC	Neutral
Waldencast	Neutral

Waldencast has a net margin of 0.00% compared to Synergy CHC's net margin of -60.02%.

Company	Net Margins	Return on Equity	Return on Assets
Synergy CHC	-60.02%	N/A	-30.30%
Waldencast	N/A	N/A	N/A

Summary

Synergy CHC and Waldencast tied by winning 3 of the 6 factors compared between the two stocks.

Get Synergy CHC News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNYR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SNYR vs. The Competition

Export

Metric	Synergy CHC	Personal Care Products Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$1.69M	$23.61B	$15.88B	$12.73B
Dividend Yield	N/A	4.34%	3.20%	8.86%
P/E Ratio	-0.08	19.29	13.54	25.25
Price / Sales	0.05	13.22	262,949.19	97.64
Price / Cash	N/A	27.10	57.26	52.26
Price / Book	-0.05	2.92	4.59	6.14
Net Income	-$12.34M	$1.13B	$836.00M	$349.01M
7 Day Performance	6.59%	-1.47%	-0.76%	-0.27%
1 Month Performance	-37.29%	-0.72%	-0.41%	0.68%
1 Year Performance	-95.30%	-18.71%	12.11%	14.84%

Synergy CHC Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SNYR Synergy CHC	1.9736 of 5 stars	$0.11 -1.8%	$6.25 +5,581.8%	-95.4%	$1.69M	$30.38M	N/A	40	Gap Down
ATPC Agape ATP	0.7095 of 5 stars	$2.37 flat	N/A	-96.4%	$2.37M	$1.52M	N/A	40	Gap Up
DSYWW Big Tree Cloud	N/A	$0.02 -2.2%	N/A	-5.6%	$0.00	$2.02M	N/A	82	Positive News Gap Down
DRMAW Dermata Therapeutics	N/A	$0.00 flat	N/A	-97.5%	$0.00	N/A	N/A	8	Positive News Gap Up High Trading Volume
PRENW Prenetics Global	N/A	$0.01 +45.7%	N/A	N/A	$0.00	$154.59M	N/A	1	Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SNYR) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Synergy CHC (SNYR) Competitors

SNYR vs. ATPC, DSYWW, DRMAW, PRENW, and WALDW

How does Synergy CHC compare to Agape ATP?

Summary

How does Synergy CHC compare to Big Tree Cloud?

Summary

How does Synergy CHC compare to Dermata Therapeutics?

Summary

How does Synergy CHC compare to Prenetics Global?

Summary

How does Synergy CHC compare to Waldencast?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNYR vs. The Competition

Synergy CHC Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Synergy CHC (SNYR) Competitors

SNYR vs. ATPC, DSYWW, DRMAW, PRENW, and WALDW

How does Synergy CHC compare to Agape ATP?

Which has more volatility & risk, SNYR or ATPC?

Is SNYR or ATPC more profitable?

Does the media prefer SNYR or ATPC?

Do institutionals & insiders hold more shares of SNYR or ATPC?

Which has better valuation and earnings, SNYR or ATPC?

Do analysts recommend SNYR or ATPC?

Summary

How does Synergy CHC compare to Big Tree Cloud?

Do analysts recommend SNYR or DSYWW?

Is SNYR or DSYWW more profitable?

Does the media refer more to SNYR or DSYWW?

Which has higher earnings & valuation, SNYR or DSYWW?

Summary

How does Synergy CHC compare to Dermata Therapeutics?

Is SNYR or DRMAW more profitable?

Does the media favor SNYR or DRMAW?

Do analysts prefer SNYR or DRMAW?

Which has higher earnings & valuation, SNYR or DRMAW?

Summary

How does Synergy CHC compare to Prenetics Global?

Which has better valuation & earnings, PRENW or SNYR?

Does the media favor PRENW or SNYR?

Is PRENW or SNYR more profitable?

Do analysts rate PRENW or SNYR?

Summary

How does Synergy CHC compare to Waldencast?

Do analysts rate SNYR or WALDW?

Which has stronger valuation and earnings, SNYR or WALDW?

Does the media favor SNYR or WALDW?

Is SNYR or WALDW more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNYR vs. The Competition

Synergy CHC Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools